“…These factors raise the likelihood that differential results in the clinical groups were due to the differences in primary diagnoses between the clinical groups. Many previous ERP studies report or fail to mention comorbidities of clinical patients (Endrass, Klawohn, Schuster, & Kathmann, 2008;Johannes et al, 2001;Kim et al, 2003;Kim et al, 2006;Kivircik, et al, 2003;Schall, Schön, Zerbin, Eggers, & Oades, 1996;Thibault et al, 2008). Future research with nonmedicated participants with pure diagnoses and no comorbidities would be ideal, however practical and ethical difficulties and high comorbidities have contributed to the use of medicated participants and small sample sizes, particularly in OCD research (Muller & Roberts, 2005), and remain as ongoing challenges.…”